Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Rutgers University
Biotech
BMS, VCs back Ceptur with $75M for RNA meds to silence pre-mRNA
Ceptur Therapeutics snagged $75 million to test its synthetic RNA technology from Rutgers to silence pre-mRNA in the hopes of warding off competition.
Kyle LaHucik
Jan 19, 2022 7:00am
Outsmarting COVID-19 by analyzing RNA in single cells
Aug 21, 2020 9:20am
FDA authorizes saliva-based coronavirus test for at-home use
May 8, 2020 4:31pm
Rutgers' saliva-based test nets FDA green light for COVID-19
Apr 13, 2020 3:55pm
Insights into organ growth in fruit flies shed light on genetic diseases
Feb 21, 2019 12:03pm
New discoveries in cancer and antibiotics resistance—News of Note
Feb 11, 2019 2:17pm
